Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M802848200 on May 14, 2008

J. Biol. Chem., Vol. 283, Issue 29, 19879-19887, July 18, 2008
This Article
Free via Author's Choice: AC
Right arrow AC Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrowAC All Versions of this Article:
283/29/19879    most recent
M802848200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gratz, N.
Right arrow Articles by Kovarik, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gratz, N.
Right arrow Articles by Kovarik, P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Group A Streptococcus Activates Type I Interferon Production and MyD88-dependent Signaling without Involvement of TLR2, TLR4, and TLR9*Formula

Nina Gratz{ddagger}, Maria Siller{ddagger}, Barbara Schaljo{ddagger}, Zaid A. Pirzada{ddagger}1, Irene Gattermeier{ddagger}, Ivo Vojtek{ddagger}, Carsten J. Kirschning§, Hermann Wagner§, Shizuo Akira, Emmanuelle Charpentier{ddagger}2, and Pavel Kovarik{ddagger}3

From the {ddagger}Max F. Perutz Laboratories, Department of Microbiology and Immunobiology, University of Vienna, Dr. Bohr-Gasse 9, A-1030 Vienna, Austria, the §Institute of Medical Microbiology, Immunology, and Hygiene, Technical University of Munich, 81675 Munich, Germany, and the Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan

Bacterial pathogens are recognized by the innate immune system through pattern recognition receptors, such as Toll-like receptors (TLRs). Engagement of TLRs triggers signaling cascades that launch innate immune responses. Activation of MAPKs and NF-{kappa}B, elements of the major signaling pathways induced by TLRs, depends in most cases on the adaptor molecule MyD88. In addition, Gram-negative or intracellular bacteria elicit MyD88-independent signaling that results in production of type I interferon (IFN). Here we show that in mouse macrophages, the activation of MyD88-dependent signaling by the extracellular Gram-positive human pathogen group A streptococcus (GAS; Streptococcus pyogenes) does not require TLR2, a receptor implicated in sensing of Gram-positive bacteria, or TLR4 and TLR9. Redundant engagement of either of these TLR molecules was excluded by using TLR2/4/9 triple-deficient macrophages. We further demonstrate that infection of macrophages by GAS causes IRF3 (interferon-regulatory factor 3)-dependent, MyD88-independent production of IFN. Surprisingly, IFN is induced also by GAS lacking slo and sagA, the genes encoding cytolysins that were shown to be required for IFN production in response to other Gram-positive bacteria. Our data indicate that (i) GAS is recognized by a MyD88-dependent receptor other than any of those typically used by bacteria, and (ii) GAS as well as GAS mutants lacking cytolysin genes induce type I IFN production by similar mechanisms as bacteria requiring cytoplasmic escape and the function of cytolysins.


Received for publication, April 14, 2008

Author's Choice—Final version full access.

* This work was supported in part by Austrian Research Foundation Grants P16726 [GenBank] -B14, I27-B03, and SFB F28 (to P. K.) and Grant P17238 [GenBank] -B09 (to E. C.); the University Jubilee Foundation of the City of Vienna (Hochschuljubiläumsstiftung der Stadt Wien, HJST) Grant H-1020-2004 (to E. C.); and the European Science Foundation under the EUROCORES Programme Euro-DYNA through Contract ERAS-CT-2003-980409 of the European Commission, DG Research, FP6 (to the laboratory of P. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Fig. 1.

1 Recipient of a scholarship from the Higher Education Commission of Pakistan (laboratory of E. C.).

Author's Choice

Creative Commons Attribution Non-Commercial License applies to Author Choice Articles

2 To whom correspondence may be addressed. Tel.: 431-4277-54608; Fax: 431-4277-9546; E-mail: emanuelle.charpentier{at}univie.ac.at. 3 To whom correspondence may be addressed. Tel.: 431-4277-54608; Fax: 431-4277-9546; E-mail: pavel.kovarik{at}univie.ac.at.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
J. C. Miller, Y. Ma, J. Bian, K. C. F. Sheehan, J. F. Zachary, J. H. Weis, R. D. Schreiber, and J. J. Weis
A Critical Role for Type I IFN in Arthritis Development following Borrelia burgdorferi Infection of Mice
J. Immunol., December 15, 2008; 181(12): 8492 - 8503.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement